Oncology

A Wealth of Experience

We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes:

  • Basal cell carcinoma
  • Bladder cancer
  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Endometrial cancer
  • Gastric cancer
  • Glioblastoma multiforme
  • Head and neck cancer
  • Large B-cell lymphoma
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Melanoma
  • Myelofibrosis
  • Neuroendocrine tumors
  • Non-Hodgkin’s lymphoma
  • Renal cell carcinoma
  • Osteosarcoma
  • Ovarian cancer
  • Pancreatic cancer
  • Peritoneal cancers
  • Prostate cancer
  • Thyroid cancer

Types of Projects

We have implemented studies to help our clients develop strategies in the oncology market and to develop and gain 
market access for products to treat cancer and complications arising from treatment of cancer illnesses. 

Recent projects have included:

Our Experts

Marco Boeri
Senior Economist
Anita Brogan
Vice President, Decision Analytic Modeling, Health Economics
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Dee Dee Mladsi (she/her)
Vice President, Health Economics—Strategy and Early Modeling
Elizabeth B. Andrews
Vice President, Emeritus, Epidemiology
Bintu Sherif
Director, Biostatistics
Kenneth J Rothman
Distinguished Fellow, Vice President of Epidemiology Research
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Stephanie Barrows
Executive Director, Market Access and Outcomes Strategy
Annete Njue
Senior Director, Market Access and Outcomes Strategy
Christopher N. Graham
Senior Director, Health Economics
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Colleen Castro
Associate Director, Market Access and Outcomes Strategy
Sorrel Wolowacz
Head, European Health Economics
Alicia Gilsenan
Vice President, Epidemiology
Xiaolei Zhou
Director, Biostatistics
Kelly Hollis
Vice President, Surveys and Observational Studies
Katie Houghton
Director, Health Economics
Isobel Pearson
Senior Director, Health Economics, Health Technology Assessment
Juliana Meyers
Director, Health Economics
Chris Knight
Senior Director, Health Economics
William L Herring
Senior Director, Health Economics
Carol Mansfield
Senior Economist and Head, Health Preference Assessment
Dawn Odom
Vice President, Biostatistics
Katherine Hicks
Senior Director, Health Economics
Jonathan Graham
Director, Health Economics
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Michele Wilson
Senior Director, Health Economics
Marci Clark
Director, Patient-Centered Outcomes Assessment
Costel Chirila
Director, Biostatistics
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Caroline Ling
Executive Director and HTA Specialist, Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Christine Poulos
Senior Economist and Vice President, Health Preference Assessment
Joan Fortuny
Director, Epidemiology
Ryan Ziemiecki
Director, Biostatistics
Lia Gutierrez
Senior Director, Epidemiology
Keith Davis
Senior Director, Health Economics
Mark Price
Senior Director, Health Economics
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
James Kaye
Senior Director, Epidemiology
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Sean Candrilli
Vice President, Health Economics

Selected Recent Oncology Publications